Detalhe da pesquisa
1.
High efficacy of CD19 CAR T-cells in patients with transformed Waldenström macroglobulinemia.
Blood
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669635
2.
Obinutuzumab versus Rituximab in transplant-eligible Mantle cell lymphoma patients.
Blood
; 2024 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669626
3.
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
N Engl J Med
; 386(26): 2482-2494, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35657079
4.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
N Engl J Med
; 386(7): 629-639, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904798
5.
CARD11 gain of function upregulates BCL2A1 expression and promotes resistance to targeted therapies combination in B-cell lymphoma.
Blood
; 142(18): 1543-1555, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562004
6.
Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.
Blood
; 140(24): 2584-2593, 2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36122385
7.
Obinutuzumab plus lenalidomide in advanced, previously untreated follicular lymphoma in need of systemic therapy: a LYSA study.
Blood
; 139(15): 2338-2346, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34936697
8.
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L-asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T-cell lymphoma: A French retrospective study.
Br J Haematol
; 201(4): 673-681, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799516
9.
Ibrutinib, obinutuzumab, and venetoclax in relapsed and untreated patients with mantle cell lymphoma: a phase 1/2 trial.
Blood
; 137(7): 877-887, 2021 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33181832
10.
Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA.
Blood
; 137(17): 2307-2320, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33211799
11.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031755
12.
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.
Hematol Oncol
; 41(1): 108-119, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251503
13.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet
; 397(10277): 892-901, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676628
14.
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
J Antimicrob Chemother
; 77(9): 2546-2556, 2022 08 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748614
15.
Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma.
Haematologica
; 107(9): 2163-2172, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172560
16.
The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition.
Haematologica
; 107(12): 2905-2917, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35263985
17.
Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study.
Acta Oncol
; 61(11): 1332-1338, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214787
18.
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
N Engl J Med
; 379(10): 934-947, 2018 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184451
19.
Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial.
Blood
; 133(18): 1964-1976, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30850381
20.
Diagnosis and prognosis are supported by integrated assessment of next-generation sequencing in chronic myeloid malignancies. A real-life study.
Haematologica
; 106(3): 701-707, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32241844